TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive Patient Advocacy: Committee To Advise NCI On Formation Of Liaison Group February 28, 1997